dangerous manifestation
early antimicrobial treatment
majority
patients
persistent forms
mechanisms
persistent forms
Lyme
Patients
late manifestations
response
therapy
incomplete resolution
Persistent
infection
prolonged antimicrobial treatment
controversial clinical efficacy
Recent evidences
reoccurrence
adverse environmental conditions
Several promising FDA-approved drugs
excellent antipersister activity
combination
use
poor effectiveness
notion
careful consideration
clinical management
order
long-term complications
